SE0602446L - Ny användning av kända farmakologiskt aktiva kemiska sammansättningar - Google Patents

Ny användning av kända farmakologiskt aktiva kemiska sammansättningar

Info

Publication number
SE0602446L
SE0602446L SE0602446A SE0602446A SE0602446L SE 0602446 L SE0602446 L SE 0602446L SE 0602446 A SE0602446 A SE 0602446A SE 0602446 A SE0602446 A SE 0602446A SE 0602446 L SE0602446 L SE 0602446L
Authority
SE
Sweden
Prior art keywords
pharmacologically active
chemical compositions
new use
active chemical
alpha
Prior art date
Application number
SE0602446A
Other languages
English (en)
Inventor
Stefan Pierzynowski
Original Assignee
Entress Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entress Ab filed Critical Entress Ab
Priority to SE0602446A priority Critical patent/SE0602446L/sv
Priority to PCT/EP2007/062333 priority patent/WO2008058993A2/en
Publication of SE0602446L publication Critical patent/SE0602446L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SE0602446A 2006-11-16 2006-11-16 Ny användning av kända farmakologiskt aktiva kemiska sammansättningar SE0602446L (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0602446A SE0602446L (sv) 2006-11-16 2006-11-16 Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
PCT/EP2007/062333 WO2008058993A2 (en) 2006-11-16 2007-11-14 Use of alpha ketogluaric acid for the treatment of infection with h. pylori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0602446A SE0602446L (sv) 2006-11-16 2006-11-16 Ny användning av kända farmakologiskt aktiva kemiska sammansättningar

Publications (1)

Publication Number Publication Date
SE0602446L true SE0602446L (sv) 2008-05-17

Family

ID=38814302

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602446A SE0602446L (sv) 2006-11-16 2006-11-16 Ny användning av kända farmakologiskt aktiva kemiska sammansättningar

Country Status (2)

Country Link
SE (1) SE0602446L (sv)
WO (1) WO2008058993A2 (sv)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (sv) * 1970-10-06 1974-05-21
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
SE0200256D0 (sv) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
WO2006043336A1 (ja) * 2004-10-20 2006-04-27 Kotobuki Pharmaceutical Co., Ltd. 胃粘膜疾患の治療又は予防のための組成物
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
KR20080102372A (ko) * 2006-01-19 2008-11-25 엔트레스 에이비 진단 방법 및 치료 방법
PL226695B1 (pl) * 2006-07-03 2017-08-31 Danuta Kruszewska Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori

Also Published As

Publication number Publication date
WO2008058993A3 (en) 2008-11-20
WO2008058993A2 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
MA33467B1 (fr) Promédicaments comprenant un conjugué insuline-lieur
MX2011012122A (es) Derivados de tiofeno.
UA108363C2 (uk) Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
SG166115A1 (en) Pharmaceutical preparation containing meloxicam
UY32599A (es) Formulación oral sólida de abt-263
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
BRPI0414581A (pt) derivados de benzimidazol: preparação e aplicações farmacêuticas
UA105229C2 (uk) Фармацевтичний склад
MY158974A (en) Prodrugs comprising an exendin linker conjugate
NO20043367L (no) Oralt farmasoytisk preparat
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
MY148844A (en) Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
UA93393C2 (uk) 1,3-діоксанкарбонові кислоти
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
IL193252A0 (en) N-hydroxyacrylamide compounds
MX2012002785A (es) Derivado de indenona y composicion farmaceutica que comprende el mismo.
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
MA33463B1 (fr) Compositions à dose pharmaceutique solide fixe comprenant de l'irbésartan et de l'amlodipine, leur préparation et leur application thérapeutique
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
WO2007144083A3 (de) Ache-nmda-kombinationswafer
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
MX2009008463A (es) Formulaciones biodisponibles de compuestos heterociclicos.
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
TW200728281A (en) Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions

Legal Events

Date Code Title Description
NAV Patent application has lapsed